News
Two-dose bivalent vaccine for the human papilloma virus (HPV) becomes available in China, in an effort to better help women fight cervical cancer, according to British drugmaker GlaxoSmithKline.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results